Gossamer Bio: Peers

The FY2025 (Dec) proxy of Gossamer Bio names 19 peer companies for pay. Among Gossamer Bio and these peers, CEO pay was the lowest of 7 and total shareholder return was 4th highest of 7.

7th highest of 7in Gossamer Bio and its pay peers, FY2025 (Dec) by CEO pay:

$2.3M$6.1M

4th highest of 7in Gossamer Bio and its pay peers, FY2025 (Dec) by total shareholder return:

$9$15,536

Pay peer group, FY2025 (Dec) proxy

Anaptysbio
Trevi Therapeutics
Annexon
aTYR Pharma
Atea Pharmaceuticals
Fulcrum Therapeutics
ACELYRINNot disclosedNot disclosed
AlectorNot disclosedNot disclosed
AllakosNot disclosedNot disclosed
AlloVirNot disclosedNot disclosed
Allogene TherapeuticsNot disclosedNot disclosed
ErascaNot disclosedNot disclosed
Kodiak SciencesNot disclosedNot disclosed
Mersana TherapeuticsNot disclosedNot disclosed
Mineralys TherapeuticsNot disclosedNot disclosed
Poseida TherapeuticsNot disclosedNot disclosed
RAPT TherapeuticsNot disclosedNot disclosed
Ventyx BiosciencesNot disclosedNot disclosed
Zentalis PharmaceuticalsNot disclosedNot disclosed
19 companies

Changes by year

FY2025 (Dec) proxy

  • AddedACELYRINpay peer group
  • AddedKodiak Sciencespay peer group
  • AddedMineralys Therapeuticspay peer group
  • AddedVentyx Biosciencespay peer group
  • AddedZentalis Pharmaceuticalspay peer group
  • AddedaTYR Pharmapay peer group
  • RemovedReneo Pharmaceuticalspay peer group

FY2024 (Dec) proxy

  • AddedACELYRINpay peer group
  • AddedKodiak Sciencespay peer group
  • AddedMineralys Therapeuticspay peer group
  • AddedVentyx Biosciencespay peer group
  • AddedZentalis Pharmaceuticalspay peer group
  • AddedaTYR Pharampay peer group
  • RemovedReneo Pharmaceuticalspay peer group

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.